Alkaptonuria Drugs Market: Enzyme Inhibitors - Highly Promising Drug Segment

03 Feb 2021
www.biospace.com
Generic Drug
Alkaptonuria: Rare Form of Disease Shows Major Symptoms in Adulthood Alkaptonuria is a rare form of a genetic metabolic disorder characterized by the accumulation of homogentisic acid in the body. This disease is also called black urine disease or black bone disease. Affected people may have dark urine or urine that turns black when exposed to air. However, this change may not occur for several hours after urination and often goes unnoticed. Read Report Overview - Black urine is main symptom in this disease which is present from birth. However, more symptoms can be observed in adulthood. The disorder is caused by mutation of the homogentisate 1, 2-dioxygenase (HGD) gene. Symptoms of this disease include ochronosis, eye sclera discoloration, tendonitis, and long-standing conditions leading to arthritis No medications are known to be useful in managing alkaptonuria. However, symptomatic relief can be provided by different classes of drugs. Also, several drugs are in investigational phase for the treatment of alkaptonuria. Request Brochure of Report - Key Drivers and Restraints of Global Alkaptonuria Drugs Market Increase in new reported cases of alkaptonuria is the major factor responsible for the growth of the global alkaptonuria drugs market For instance, according to an article published in the Journal of Rare Diseases on December 2013, the worldwide prevalence of alkaptonuria is 1 case in 250,000–1,000,000 births and total 950 alkaptonuria patients was identified in 40 countries by the end of 2013 Rise in awareness about alkaptonuria disease and clinical investigational therapies for the disease are some of the major factors fuelling the growth of the global alkaptonuria market Patient assistance programs and different support programs in terms of treatment and research run by different organizations for alkaptonuria have further contributed to the growth of the global alkaptonuria drugs market Ineffective Treatment Methods Hamper Market Growth Not much medications are available which can be fully described as effective options for the treatment for alkaptonuria. This unavailability of effective treatment options is hampering the market growth. Inadequate knowledge of the disease in some developing countries can also restrain the market growth Request for Analysis of COVID-19 Impact on Alkaptonuria Drugs Market - Enzyme Inhibitors - Highly Promising Drug Segment Based on drug class, the global alkaptonuria drugs market can be divided into vitamins, enzyme Inhibitors, and others Enzyme inhibitors include mainly Nitisinone which is a highly promising drug candidate for the treatment of alkaptonuria. This segment is anticipated to be a highly lucrative segment in the next few years due to ongoing clinical trials and availability of branded and generic options in this category. Vitamin C (ascorbic acid) is the major vitamin used for various metabolic processes. Mild antioxidant nature of vitamin C helps to retard the process of conversion of homogentisate to the polymeric material that is deposited in cartilaginous tissues. Oral Route of Administration Dominated Global Market In terms of route of administration, the global alkaptonuria drugs market can be bifurcated into oral and injectable Oral route of administration dominated the global alkaptonuria drugs market due to accurate unit dosage forms by tablets & capsules in adults and higher preference in children for suspension Request for Custom Research - Online Pharmacies to be Promising Segment On the basis of distribution channel, the global alkaptonuria drugs market is classified into hospital pharmacies, retail pharmacies, and online pharmacies Easy availability of branded as well as generic drugs and easy access to retail pharmacies are some of the major factors responsible for the dominance of the retail pharmacies segment The online pharmacies segment is expected to be a highly lucrative segment during the forecast period due to rise in preference of online purchase by people and better discounted rates available at these stores. North America to Lead Global Alkaptonuria Drugs Market In terms of region, the global alkaptonuria drugs market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa Europe dominated the global alkaptonuria drugs market in 2018 due to higher number of reported cases of alkaptonuria in the region, ongoing clinical trials, and better awareness regarding disease & its management For instance, according to an article published in the Journal of Rare Diseases on December 2013, total 206 patients in Slovakia and 90 patients in Germany were identified for alkaptonuria by the end of 2013 Asia Pacific is anticipated to be a lucrative market for alkaptonuria drugs during the forecast period due to higher alkaptonuria patient population in some countries such as India, growing awareness of disease, and rise in focus and presence of companies in the region due to major market opportunities in this region Pre Book Alkaptonuria Drugs Market Report at <ype=S Key Manufacturers Operating in Global Market Key manufacturers operating in the global market are: CYCLE Pharmaceuticals Limited Sobi, Inc. Emerge Health Menarini Australia Pty Ltd uniQure N.V. GlaxoSmithKline plc Sanofi Pfizer Inc. Teva Pharmaceutical Industries Ltd. Mylan N.V. Browse More Trending Reports by Transparency Market Research: Over the Counter (OTC) Test Market: Alport Syndrome Market: Female Infertility Drugs Market: About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website:
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.